{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:22:36Z","timestamp":1793992956093,"version":"4.8.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111034","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T07:47:42Z","timestamp":1761637662000},"page":"111034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The contribution of IL-10 and IL-6 as potential biomarkers for detecting central nervous system involvement in non-Hodgkin lymphomas"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-5083","authenticated-orcid":false,"given":"Elisa","family":"Buzzatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Christina","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ombretta","family":"Annibali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Santinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Irno-Consalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovangiacinto","family":"Paterno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cardillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Postorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-0553","authenticated-orcid":false,"given":"Adriano","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilaria","family":"Del Principe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinbiochem.2025.111034_b0005","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood-2017-03-737460","article-title":"How I treat patients with aggressive lymphoma at high risk of CNS relapse","volume":"130","author":"Chin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2025.111034_b0010","doi-asserted-by":"crossref","unstructured":"Gleeson, M., Counsell, N., Cunningham, D., Chadwick, N., Lawrie, A., Hawkes, E. A., McMillan, A., Ardeshna, K. M., Jack, A., Smith, P., & et al. (2017). Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma in the Rituximab Era: Results of the UK NCRI R-CHOP-14 versus 21 Trial.Annals of Oncology,28, 2511\u20132516. https:\/\/doi.org\/10.1093\/annonc\/mdx353.","DOI":"10.1093\/annonc\/mdx353"},{"key":"10.1016\/j.clinbiochem.2025.111034_b0015","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/dc.23539","article-title":"Accuracy of Flow Cytometry and Cytomorphology for the Diagnosis of Meningeal Involvement in Lymphoid Neoplasms: a Systematic Review: Flow Cytometry and Cytology in Meningeal Lymphoid Neoplasms","volume":"44","author":"Canovi","year":"2016","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.clinbiochem.2025.111034_b0020","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.29.10.1369","article-title":"Malignant Cells in Cerebrospinal Fluid (CSF): the Meaning of a positive CSF Cytology","volume":"29","author":"Glass","year":"1979","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111034_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1470-2045(05)70513-1","article-title":"Inherited cytokine response and risk of lymphoma","volume":"7","author":"Salles","year":"2006","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.clinbiochem.2025.111034_b0030","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clinbiochem.2025.111034_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2020.12263","article-title":"Clinical significance of Interleukin-10 Concentration in the Cerebrospinal Fluid of patients with Primary Central nervous System Lymphoma","volume":"21","author":"Geng","year":"2020","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.clinbiochem.2025.111034_b0040","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/S2352-3026(24)00104-2","article-title":"Molecular diagnosis of primary CNS lymphoma in 2024 usingMYD88Leu265Proand IL-10","volume":"11","author":"Calimeri","year":"2024","journal-title":"The Lancet Haematology"},{"issue":"10","key":"10.1016\/j.clinbiochem.2025.111034_b0045","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/ajh.25578","article-title":"Optimization of CSF biological investigations for CNS lymphoma diagnosis","volume":"94","author":"Armand","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2025.111034_b0050","doi-asserted-by":"crossref","unstructured":"Fisson, S., Ouakrim, H., Touitou, V., Baudet, S., Ben Abdelwahed, R., Donnou, S., Miloudi, A., Galand, C., Bodaghi, B., LeHoang, P., & et al. (2013). Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis.PLoS ONE,8(12), e52385. https:\/\/doi.org\/10.1371\/journal.pone.0052385.","DOI":"10.1371\/journal.pone.0052385"},{"issue":"18","key":"10.1016\/j.clinbiochem.2025.111034_b0055","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.3390\/cancers15184440","article-title":"Serum Paraprotein is Associated with adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies-a Systematic Review","volume":"15","author":"Cox","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clinbiochem.2025.111034_b0060","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1186\/s12885-024-13195-5","article-title":"Cerebrospinal fluid IL-6 and IL-10 as promising diagnostic and therapeutic prognostic biomarkers for secondary central nervous system lymphoma","volume":"24","author":"Gu","year":"2024","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.clinbiochem.2025.111034_b0065","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00262-020-02778-3","article-title":"IL-10, IL-13, Eotaxin and IL-10\/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas","volume":"70","author":"Di Napoli","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clinbiochem.2025.111034_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156289","article-title":"Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes","volume":"169","author":"Bao","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.clinbiochem.2025.111034_b0075","doi-asserted-by":"crossref","unstructured":"Melli, B., Gentile, P., Nicoli, D., & et al. (2022). Primary Vitreoretinal Lymphoma: Current Diagnostic Laboratory Tests and New Emerging Molecular Tools.Current Oncology,29(10), 6908\u20136921. https:\/\/doi.org\/10.3390\/curroncol29100543.","DOI":"10.3390\/curroncol29100543"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:41:46Z","timestamp":1783158106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":15,"alternative-id":["S0009912025001638"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111034","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of IL-10 and IL-6 as potential biomarkers for detecting central nervous system involvement in non-Hodgkin lymphomas","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111034"}}